Bio-Techne logo

TECH - Bio-Techne Share Price

$220.61 1.2  0.5%

Last Trade - 17/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £6.46bn
Enterprise Value £6.72bn
Revenue £564.5m
Position in Universe 891st / 6415
Bullish
Bearish
Unlock TECH Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

TECH Revenue Unlock TECH Revenue

Net Income

TECH Net Income Unlock TECH Revenue

Normalised EPS

TECH Normalised EPS Unlock TECH Revenue

PE Ratio Range

TECH PE Ratio Range Unlock TECH Revenue

Dividend Yield Range

TECH Dividend Yield Range Unlock TECH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
TECH EPS Forecasts Unlock TECH Revenue
Profile Summary

Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms useful in various areas of protein analysis. The Diagnostics and Genomics reporting segment provides blood chemistry and blood gas quality controls, hematology instrument controls, diagnostics immunoassays and other bulk and custom reagents for the in vitro diagnostic market.

Directors
Last Annual June 30th, 2019
Last Interim September 30th, 2019
Incorporated July 17, 1981
Public Since February 9, 1989
No. of Shareholders: 43,000
No. of Employees: 2,250
Sector Healthcare
Industry Biotechnology & Medical Research
Index S&P 400 Mid Cap , Nasdaq Composite , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 38,112,184
Free Float (0.0%)
Eligible for
ISAs
SIPPs
TECH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for TECH
Upcoming Events for TECH
Similar to TECH
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.